Changes in intracellular redox status are crucial events that trigger downstream proliferation or death responses through activation of specific signaling pathways. Moreover, cell responses to oxidative challenge may depend on the pattern of redox-sensitive molecular factors. The stress-activated protein kinases c-Jun-N-terminal kinase (JNK) and p38 MAP kinase (p38 MAPK ) are implicated in different forms of apoptotic neuronal cell death. Here, we investigated the effects, on neuroblastoma cells, of the prooxidant molecule GSSG, which we previously demonstrated to be an efficient proapoptotic compound able to activate the p38 MAPK death pathway in promonocytic cells. We found that neuroblastoma cells are not prone to GSSG-induced apoptosis, although the treatment slightly induced growth arrest through the accumulation of p53 and its downstream target gene, p21. However, GSSG treatment became cytotoxic when cells were previously depleted of intracellular GSH content. Under this condition, apoptosis was triggered by an increased production of superoxide that led to a specific activation of the JNK-dependent pathway. The involvement of superoxide and JNK was demonstrated by cell death inhibition in experiments carried out in the presence of Cu,Zn superoxide dismutase or with specific inhibitors of JNK activity. Our data give support to the studies that indicate preferential requirements for the involvement of stress-activated kinases in apoptotic neuronal cells.
Introduction
Reactive oxygen species (ROS) have been traditionally considered to be damaging to cells. However, a large number of evidence has shown that ROS may also function as important activators of key physiological processes playing a vital role in the cell signaling network [1 -3] . The ROS-mediated signaling network relies on a dynamic regulation of the oxidized/reduced form of redox-sensitive proteins containing critical cysteines. In this context, glutathione, the most abundant low molecular weight thiol within the cell [4] , represents the main buffer system regulating the redox state of these proteins [5] .
In the last few years, a direct link between mitogenactivated protein (MAP) kinases signaling network and ROS production has been suggested. In fact, it has been found that redox-sensitive proteins, such as thioredoxin and glutathione S-transferase (GST), can directly bind and inactivate apoptosis signal-regulating kinase 1 (ASK1) and JNK1, respectively [6, 7] . Under redox unbalance GST and thioredoxin are induced to dissociate, due to the oxidation of specific cysteine residues, thus leading to the activation of their MAP kinase partners. As a result, ASK1 and JNK1 are able to autoactivate and transduce the signal by phospho-activating downstream effectors. This sequence of events represents the switch able to transform a specific redox change (thiol/ disulfide) in a phosphorylative potential that may act in a broad range within the cell.
Previously, we demonstrated that exogenous GSSG, a membrane-impermeable oxidizing molecule, was able to induce, in U937 promonocytic cells, a rapid alteration of intracellular GSH levels by shifting the equilibrium toward the formation of mixed disulfides with protein thiols [8] . This redox unbalance triggered an apoptotic response by the activation of the canonical mitochondrial pathway, which was preceded by dissociation of the thioredoxin/ASK1 complex and phospho-activation of the p38 MAP kinase (p38 MAPK ) pathway. We postulated that such responses could be mediated by specific trans-membrane proteins rich in cysteine residues, which transduce the oxidizing power of GSSG across the plasma membrane through a thiol/disulfide exchange. Since the activation of ASK1/p38 MAPK pathway is also involved in cell response mediated by the engagement of ligands to cysteine-rich death receptors [i.e., those belonging to tumor necrosis factor (TNF) superfamily], we hypothesized that the transduction of oxidizing power could also occur through these trans-membrane proteins. This hypothesis was supported by the evidences that leukemia cells express TNF superfamily-related death receptors [i.e., TNF-related apoptosis-inducing ligand (TRAIL) receptors] at high levels on membrane surfaces, and GSSG was not toxic when added to differentiated macrophages or lymphocytes, although high concentrations were used.
In order to verify whether the cell response to GSSG treatment was hystotype-dependent, we determined the effects of GSSG on neuroblastoma cells. In particular, we found that these cells were resistant to GSSG unless depleted of glutatione content. Focusing on the MAPK signaling pathway activated by GSSG treatment under glutatione deprivation, we found that the predominant MAP kinase pathway to be induced was that mediated by JNK. The results may provide a better understanding about the contribution of cell-specific redox-sensitive proteins in the different cellular responses to oxidative stimuli.
Materials and methods

Materials
Oxidized glutathione (GSSG) was from Roche Molecular Biochemicals (Monza, Italy). D,L-Buthionine-S,R sulfoximine (BSO), propidium iodide, protease inhibitor cocktail, IGEPAL CA-630, and anti-p53 (clone BP53-12) and antiactin (clone AC-40) monoclonal antibodies were obtained from Sigma (St. Louis, MO). Anti-p21(clone C-19) polyclonal antibody, monoclonal anti-p-JNK (G-7), and anti p-cJun (KM-1) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Polyclonal anti-phospho-p38 MAP kinase (Thr180/Tyr182) was from Cell Signaling Technology-New England BioLabs (Beverly, MA). Hoechst 33342, C 5 -maleimide Alexa Fluor and 2V ,7V -dichlorofluorescein diacetate (DCF-DA) were from Molecular Probes (Eugene, OR). IgG (H+L)-HRP-conjugated goat anti-mouse and antirabbit secondary antibodies were from Bio-Rad Lab. (Hercules, CA). SuperSignal substrate chemiluminescent reagent was from Pierce (Rockford, IL). All other chemicals were obtained from Merck (Darmstadt, Germany).
Cell cultures
Human neuroblastoma cells SH-SY5Y were purchased from the European Collection of Cell Culture and grown in Dulbecco's modified Eagle's/F12 medium supplemented with 15% fetal calf serum, at 37-C in an atmosphere of 5% CO 2 in air. A monoclonal cell line transfected with human wild-type Cu,Zn superoxide dismutase (hSOD cells) was obtained as previously described [9] . Cells were routinely trypsinized and plated at 30 Â 10 5 /75-cm 2 flasks. Cell viability was assessed by trypan blue exclusion.
Treatments
GSSG solution was prepared by dissolving the purified compound in PBS (phosphate-buffered saline, 10 mM phosphate buffer, 2.7 mM KCl, 137 mM NaCl, pH 7.4), buffered at pH 5.5 with NaOH, and sterilized by filtration. GSSG was used at concentration of 1 mM at 37-C in medium supplemented with serum on the basis of previous results obtained with promonocytic cells [8] . Treatment with BSO was performed at a concentration of 1 mM for 6 h before the addition of GSSG and maintained in culture media throughout the experiments. Catalase or Cu,Zn superoxide dismutase (Cu,Zn SOD) were added concomitantly with GSSG and used at a concentration of 1 AM. Treatments with the cell-permeable JNK inhibitor I and II (SP600125) or p38 MAPK inhibitor SB203580 (Calbiochem, La Jolla, CA) were performed at a concentration of 10 AM because lower concentrations did not show significant inhibition and higher concentrations were toxic. All the compounds were added concomitantly with BSO and maintained throughout the experiments.
Detection of intracellular ROS
For detection of intracellular ROS, cells were incubated with 50 AM DCF-DA for 30 min at 37-C, scraped, washed, and resuspended in ice-cold PBS. The fluorescent signals derived by reaction of DCF with ROS, of more than 10,000 cells from each sample, were analyzed by recording FL-1 fluorescence by the FACScalibur system. Prior to data collection, propidium iodide was added to the samples for gating out dead cells. Experiments were repeated at least three times with similar results. The data are given as one representative histogram.
Detection of exofacial sulfhydryls
For detection of external plasma membrane thiols, cells were incubated with 10 AM Alexa Fluor C 5 -maleimide for 1 h at 37-C. Labeled thiols were visualized by fluorescent microscopy and images of cells were rapidly digitized with a Cool Snap video camera connected to Nikon Eclipse TE200 epifluorescence microscopy. All images were captured under constant exposure time, gain, and offset. Alternatively, cells were scraped, washed, and resuspended in ice-cold PBS and analyzed cytofluorimetrically by recording FL1 fluorescence. The data are given as one representative histogram.
Analysis of cell proliferation and apoptosis
Cell viability was assessed by performing direct counting of cells upon staining with the vital dye trypan blue using a hemocytometer. Nuclear fragmentation was detected by optical microscopy on slides by vital staining with the DNA-specific cell-permeable dye Hoechst 33342. The fraction of cells with fragmented nuclei among the total cell population was calculated using Hoechst 33342-stained cells, counting at least 300 cells in at least 10 randomselected fields as described [10] . Alternatively, cells were washed with PBS, stained with 50 AM propidium iodide solution [11] , and analyzed by a FACScalibur system (Becton Dickinson, San Josè, CA).
Western blot analyses
Cell pellets were resuspended in lysis buffer containing 10 mM Tris-HCl, pH 7.4, 5 mM EDTA, 150 mM NaCl, 0.5% IGEPAL CA-630, and protease inhibitor cocktail. After 30 min incubation on ice, lysates were centrifuged at 22,300 g for 15 min at 4-C and supernatants were removed and stored at À80-C. Protein extracts were loaded on 12% polyacrylamide gel and transferred onto a nitrocellulose membrane (Millipore, Bedford, MA). Anti-phospho-JNK (1:200), anti-phospho-c-Jun (1:200), anti-p53 (1:5000), antiactin, anti-phospho-p38 (1:1000), and anti-p21 (1:2000) were used as primary antibodies. Appropriate HRP-conjugated secondary antibodies were used to detect immunoreactive bands by incubation with SuperSignal substrate chemiluminescence reagent. Actin was used as loading control. Densitometric analyses were calculated using Quantity One Software (Bio-Rad) and data were normalized with respect to the actin band. Data are reported as arbitrary units with respect to control which was considered equal to 1.00. Immunoblots reported are from one experiment of three that gave similar results.
Glutathione determination
Intracellular glutathione was assayed upon formation of S-carboxymethyl derivatives of free thiols with iodoacetic acid, followed by the conversion of free amino groups to 2,4-dinitrophenyl derivatives by the reaction with 1-fluoro-2,4-dinitrobenzene as described by Reed et al. [12] . Cell suspension was washed three times with PBS in order to completely eliminate exogenous GSSG, resuspended, and lysed by repeated cycles of freezing and thawing under liquid nitrogen. Lysates were then divided into two aliquots: one utilized for GSH/GSSG assay, while the other was used to determine mixed disulfides by treating with 300 mM NaBH 4 at 40-C for 30 min prior to derivatization, as described previously [13] . Data are expressed as nanomoles of GSH or GSSG per milligram protein. Proteins were determined by the method of Lowry et al. [14] .
Data presentation
All experiments were done with n = 6 unless otherwise stated. Each assay was performed at least in triplicate under identical conditions. The results are presented as means T SD. Statistical evaluation was conducted by ANOVA, followed by correction with Bonferroni's. Comparisons were considered to be significant at P < 0.05.
Results
GSSG treatment does not induce apoptosis in SH-SY5Y neuroblastoma cells
We previously demonstrated that externally added GSSG acts as a prooxidant and proapoptotic molecule in human promonocytic U937 cells [8] . The first step of the present study was to verify whether GSSG-mediated toxicity could represent a widespread phenomenon, independent on the cell type. To this end, the dose of 1 mM GSSG, that was successful in inducing apoptosis in promonocytic cells, was supplied to SH-SY5Y neuroblastoma cells. Cell cycle analyses, as well as routine morphological examination, revealed that SH-SY5Y cells were resistant to GSSGinduced apoptosis. In fact, counting of direct viable cells evidenced only a slight inhibition of cell growth after 48 h of GSSG administration (Fig. 1A) . This phenomenon was paralleled by a slight increase in the expression level of cell cycle regulators p53 and p21, as demonstrated by Western blot analyses of total cell lysates (Fig. 1B) . Moreover, these events were not associated with induction of cell death, as the number of fragmented nuclei after DNA-specific dye with Hoechst 33342 (marker of apoptosis) or lactic dehydrogenase activity in culture media (marker of necrosis) were not significantly different from untreated cells (data not shown).
To further elucidate the GSSG inefficacy on neuroblastoma cells, we tested whether GSSG could affect the thiol redox state of plasma membrane proteins and/or intracellular compartment of this cell line. To this aim, cells were labeled with 10 AM Alexa Fluor C 5 -maleimide, a specific nonpermeable thiol-reactive compound able to recognize and covalently bind to membrane surface cysteines. Fig. 2A shows that 24 h treatment with 1 mM GSSG had no remarkable effect on extracellular thiol content. Cytofluorimetric analyses were also performed and, as shown in Fig. 2B , only a slight decrease in the green fluorescence of C 5 maleimide was detected after GSSG treatment, confirming that it was not able to efficiently oxidize extracellular cysteines residues of membrane proteins, when compared with the effects that we observed in U937 cells [8] . The ineffectiveness of GSSG treatment on surface cysteines was mirrored by an almost unchanged intracellular redox state. Indeed, only a mild alteration in intracellular GSH levels was observed after 48 h of treatment with 1 mM GSSG, due to its engagement in mixed disulfide formation with protein thiols (GS-R) (Fig.  2C) . Moreover, intracellular GSSG levels paralleled the decrease of GSH content, keeping the ratio GSH/GSSG unchanged, also confirming that externally added GSSG was not able to cross the plasma membrane (Fig. 2C) .
Depletion of intracellular GSH sensitizes SH-SY5Y cells to GSSG treatment
To determine whether the significant intracellular decrement of GSH, which was the mediator of exogenous GSSG cytotoxicity in U937, could be also effective in neuroblastoma cells, we lowered the tripeptide content of SH-SY5Y cells by treatment with 1 mM BSO, a specific inhibitor of GSH synthesis. Fig. 3 shows that BSO treatment caused a time-dependent decrease of both GSH and GSSG that was not altered by the treatment with GSSG (data not shown). Furthermore BSO treatment restored cell sensitivity to GSSG; in particular, we observed, by cytofluorimetric analyses after staining with propidium iodide that SH-SY5Y cells treated with BSO alone are committed to apoptosis to a low extent (12% after 48 h). This effect was dramatically increased with 1 mM GSSG treatment in a time-dependent manner (49 and 65% at 24 and 48 h, respectively) (Fig. 3B) . Apoptosis was associated with a strong increase in the expression levels of p21 and p53 (Fig. 3C) . Moreover, the p53-immunoreactive band was shifted to a higher molecular weight, which corresponds to the phosphorylated form of the protein [15] , indicating a stronger activation of the transcription factor under this condition (Fig. 3C) .
GSSG treatment induces the activation of JNK in GSH-depleted SH-SY5Y cells
Several studies report that under ROS challenge neuronal cells are preferentially committed to apoptotic cell death by the activation of the MAP kinase signaling pathway [16, 17]. To establish whether the effect of GSSG on SH-SY5Y-depleted cells was mediated by MAP kinases activation, we analyzed the expression levels of the phospho-activated forms of JNK and p38 MAPK . As seen in Fig. 4A , BSO treatment alone was able to efficiently induce the activation of p38 MAPK (P-p38 MAPK ) confirming that this kinase is extremely sensitive to changes of GSH content. Conversely, the combined treatment of BSO with GSSG induced a timedependent decrease in the intensity of the P-p38 MAPKimmunoreactive band from 6 to 24 h, and a significant activation of JNK (P-JNK) and its downstream target c-Jun (P-c-Jun). In order to confirm the predominant role of JNK in the induction of apoptosis by GSSG in GSH-depleted cells, we performed experiments in the presence of inhibitors of both kinases. Fig. 4B shows cytofluorimetric analyses of apoptotic cells after staining with propidium iodide. Pretreatment with JNK inhibitors I and II (SP600125) had no effect on BSO-treated SH-SY5Y, but strongly reduced apoptosis in GSH-depleted cells after 24 h incubation with GSSG (À68%). On the other hand, the p38 MAPK inhibitor, SB203580, completely reverted the even low extent of BSO-induced apoptosis, and significantly reduced the percentage of apoptotic cells after cotreatment BSO/GSSG (À12%).
GSSG induces apoptosis in GSH-depleted SH-SY5Y cells through superoxide production
In searching for the molecular mechanisms that are responsible for the induction of apoptosis under GSH depletion, we considered that g-glutamyl transpeptidase, the main enzyme involved in the Meister cycle able to catalyze the cleavage of GSH-deriving g-glutamate, is also able, but with a much lower efficiency, to catalyze the cleavage of GSSG, thus producing H 2 O 2 at the level of plasma membrane [18] . In this way, BSO treatment, by decreasing GSH content, could determine a higher sensitivity of SH-SY5Y cells to H 2 O 2 -mediated oxidative stress, with this event the real inducer of cell death. Moreover, GSSG can also produce superoxide anions (O 2 SÀ ) from the reaction between O 2 and thiyl radicals. To check these assumptions, SH-SY5Y GSH-depleted cells were incubated with DCF-DA and assayed for ROS production through cytofluorimetric analyses. Fig. 5A shows that, although ROS production was slightly influenced by BSO treatment, the percentage of increase observed in combination with GSSG treatment was significantly higher compared with untreated cells.
In 
SÀ
was the radical specie involved in the activation process (Fig. 5B) . The protective role exerted by Cu,Zn SOD was due to the efficient removal of radicals as shown by the assay of ROS with DCF-DA (Fig. 5A ).
Discussion
Previously we demonstrated that promonocytic U937 cells, treated with GSSG, were committed to cell death by apoptosis through the activation of the stress-activated protein kinase, p38
MAPK . Since, owing to its hydrophilic nature GSSG is unable to cross the cell membrane, we have hypothesized that its effects inside the cell could occur through a putative thiol/disulfide exchange relay along cysteine residues of proteins spanning across the plasma membrane. The external cysteine residues were able to transduce the prooxidant power intracellularly by shifting the GSH content toward the production of mixed disulfides. The resulting redox imbalance was responsible for p38 MAPK activation and cell death induction [8] . Here we demonstrate that this pathway is not of general application because neuroblastoma cells are resistant to GSSG treatment. The major divergence between the two cell lines was that GSSG does not efficiently oxidize exofacial cysteine thiols in neuroblastoma cells, although they are present at high concentrations. This points out that the redox potential of cysteine residues could be different, depending on the protein species; however, we cannot exclude that critical cysteines on specific membrane proteins could be modulated under those conditions. As a consequence of the unreactivity of membrane cysteines, the oxidizing power of GSSG was not efficiently transduced intracellularly, as the SH-SY5Y cells were pretreated with 1 mM BSO for 6 h before the addition of 1 mM GSSG and maintained in culture medium throughout the experiment. At 24 or 48 h after GSSG addition, apoptotic cells were determined by the FACScalibur system after staining with propidium iodide. Data are expressed as means T SD (n = 6). **P < 0.001 with respect to BSO-treated cells. (C) SH-SY5Y cells were pretreated with 1 mM BSO for 6 h before the addition of 1 mM GSSG and maintained in culture medium throughout the experiment. p53 and p21 protein levels were determined, at 24 h after GSSG addition, on total protein extracts (50 Ag) by Western blot analyses. Actin was used as loading control. The immunoblots shown are from one experiment representative of three that gave similar results. Densitometric analyses of each lane were calculated using Quantity One Software and data are expressed as arbitrary units as described under Materials and methods. Data are presented as means T SD. **P < 0.001; *P < 0.01 with respect to untreated cells; #P < 0.001 with respect to BSO-and GSSG-treated cells. P-p53: phospho-p53. However, GSSG was cytotoxic in neuroblastoma cells when the intracellular content of GSH was lowered by BSO; in fact, SH-SY5Y, depleted of GSH, loose their resistance to GSSG insult and efficiently undergo apoptosis. In the search for the molecular mechanisms underlying the sensitivity to GSSG under this condition, we took into account the opportunity for GSSG to transiently generate the thiyl radical which could efficiently react with oxygen, thus producing O 2 SÀ . Under basal conditions, due to the low extent of reaction between GSSG and protein thiols, O 2 SÀ can be efficiently scavenged by cellular antioxidant equipment, including GSH. On the contrary, in GSH-depleted cells, O 2 SÀ may become the inducer of the apoptotic process triggered by GSSG. This was nicely demonstrated by the experiments carried out in the presence of enzymatic ROS scavengers. Cell death was efficiently inhibited only by the addition of Cu,Zn SOD to the culture medium of GSHdepleted cells or by using SH-SY5Y cells overexpressing Cu,Zn SOD (Fig. 6) . These results, while in agreement with the role played by this enzyme in modulating the sensitivity of cancer cells to external or cytosolic-derived superoxide [19] , may also be in line with the ineffectiveness of Cu,Zn SOD to counteract mitochondrial-mediated ROS production [20] .
After oxidative stimuli, such as UVor hydrogen peroxide, several members of the MAP kinase family have been described to be phospho-activated on specific ser/thr residues [17, 21] . This modification leads to the activation of numerous downstream transcription factors which mediate the cell response. We propose the activation of two distinct apoptotic pathways in GSH-depleted cells. The first one is mediated by p38 MAPK and seems to be only responsive to BSO pretreatment: the level of phospho-p38 MAPK was increased in GSH-depleted cells and its inhibition completely prevented BSO-induced apoptosis (about 10%). The second one, which represents the main apoptotic pathway, is mediated by JNK. To confirm this scheme, the percentage of Fig. 5 . GSSG induces apoptotic cell death in GSH-depleted SH-SY5Y cells through production of superoxide. (A) Cells were pretreated with 1 mM BSO for 6 h before the addition of 1 mM GSSG and maintained in culture medium throughout the experiment. Thirty minutes before the indicated time points, cells were stained with DCF-DA and ROS concentration was detected by FACScalibur system. The histograms reported are from one experiment representative of three that gave similar results. hSOD, SH-SY5Y cells overexpressing human Cu,Zn SOD. (B) SH-SY5Y cells were pretreated with 1 mM BSO for 6 h before the addition of 1 mM GSSG and maintained in culture medium throughout the experiment. 1 AM catalase or 1 AM Cu,Zn SOD was added concomitantly with GSSG. Twenty-four hours after GSSG addition, apoptotic cells were determined by the FACScalibur system after staining with propidium iodide. Data are presented as means T SD (n = 4). **P < 0.001 with respect to BSO/GSSG-treated cells. cells rescued from apoptosis upon JNK inhibitors addition accounts for the majority of apoptotic cells (about 26%) and it was additional to that obtained upon treatment with BSO alone. Moreover, the appearance of a phospho-JNK-immunoreactive band becomes significantly evident as early as 6 h of treatment remaining highly expressed all during the experimental time. Therefore, these results strongly support our hypothesis [8] that p38 MAPK represents a first sensor of the GSH redox state, while JNK activation could represent the response of GSH-depleted cells to O 2 SÀ production after treatment with GSSG. The results, while confirming distinct requirements for the induction of the two MAP kinases in different forms of neuronal apoptotic death [22] , at the same time need further studies to elucidate the down-regulation/ inhibition of p38 MAPK observed upon JNK activation. Our results are also in agreement with several observations suggesting that JNK is involved in neuronal cell death during early brain development [23] , in neurodegenerative disorders [24] or under oxidative insult [25] .
Overall the results demonstrate that GSSG may behave as a proapoptotic agent by two distinct mechanisms depending on the cell type: one is mediated by direct thiol/disulfide exchange, the other by the formation of O 2 SÀ . The two mechanisms, in turn, involve two different apoptotic pathways mediated by specific MAP kinase members. This different behavior of different cell types may also provide a clue for a valuable therapeutic approach. The specific apoptotic effect exerted by GSSG on U937 could be applied in chemotherapy in order to selectively kill leukemia-derived cells without compromising the viability of other cells, especially in the case of acquired resistance to the conventional anticancer drugs. Moreover, a use of GSSG in combination with other molecules, able to decrease intracellular GSH content, could be proposed for cancer cells resistant to the GSSG treatment alone.
Work is in progress in our laboratory in order to identify the cell-specific cysteine-rich proteins able to sense GSSGmediated oxidative stimulus and to transduce it in an efficient apoptotic signal within the cell. This could be very important in order to identify new molecular targets for GSSG and to propose a selective use of this compound in cancer therapy.
